Compass Therapeutics Inc.

Compass Therapeutics Inc.

生物技术研究

Boston,MA 7,677 位关注者

We are developing next-generation antibodies into transformative cancer therapies that improve patients’ lives.

关于我们

Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’ scientific focus is on the relationship between angiogenesis, the immune system and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts. To learn more, visit www.compasstherapeutics.com

网站
https://www.compasstherapeutics.com
所属行业
生物技术研究
规模
11-50 人
总部
Boston,MA
类型
上市公司
创立
2014
领域
Drug Discovery and Development、Biologics、Oncology和Immuno-Oncology

地点

  • 主要

    80 Guest Street

    Suite 601

    US,MA,Boston,02135

    获取路线

Compass Therapeutics Inc.员工

动态

相似主页

查看职位

融资